» Articles » PMID: 33764982

Identifying Optimal COVID-19 Testing Strategies for Schools and Businesses: Balancing Testing Frequency, Individual Test Technology, and Cost

Overview
Journal PLoS One
Date 2021 Mar 25
PMID 33764982
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: COVID-19 test sensitivity and specificity have been widely examined and discussed, yet optimal use of these tests will depend on the goals of testing, the population or setting, and the anticipated underlying disease prevalence. We model various combinations of key variables to identify and compare a range of effective and practical surveillance strategies for schools and businesses.

Methods: We coupled a simulated data set incorporating actual community prevalence and test performance characteristics to a susceptible, infectious, removed (SIR) compartmental model, modeling the impact of base and tunable variables including test sensitivity, testing frequency, results lag, sample pooling, disease prevalence, externally-acquired infections, symptom checking, and test cost on outcomes including case reduction and false positives.

Findings: Increasing testing frequency was associated with a non-linear positive effect on cases averted over 100 days. While precise reductions in cumulative number of infections depended on community disease prevalence, testing every 3 days versus every 14 days (even with a lower sensitivity test) reduces the disease burden substantially. Pooling provided cost savings and made a high-frequency approach practical; one high-performing strategy, testing every 3 days, yielded per person per day costs as low as $1.32.

Interpretation: A range of practically viable testing strategies emerged for schools and businesses. Key characteristics of these strategies include high frequency testing with a moderate or high sensitivity test and minimal results delay. Sample pooling allowed for operational efficiency and cost savings with minimal loss of model performance.

Citing Articles

Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, and High-Income Countries: A Systematic Review.

Purba A, Rosyid A, Handayani S, Rachman B, Romdhoni A, Al Farabi M Med Sci Monit. 2024; 30:e943863.

PMID: 38643358 PMC: 11044836. DOI: 10.12659/MSM.943863.


Comparison of socio-economic determinants of COVID-19 testing and positivity in Canada: A multi-provincial analysis.

Antonova L, Somayaji C, Cameron J, Sirski M, Sundaram M, McDonald J PLoS One. 2023; 18(8):e0289292.

PMID: 37611032 PMC: 10446177. DOI: 10.1371/journal.pone.0289292.


Proposal of Smith-Waterman algorithm on FPGA to accelerate the forward and backtracking steps.

Oliveira F, Dias L, Fernandes M PLoS One. 2022; 17(6):e0254736.

PMID: 35772072 PMC: 9246398. DOI: 10.1371/journal.pone.0254736.


Cost-analysis of COVID-19 sample collection, diagnosis, and contact tracing in low resource setting: The case of Addis Ababa, Ethiopia.

Yigezu A, Zewdie S, Mirkuzie A, Abera A, Hailu A, Agachew M PLoS One. 2022; 17(6):e0269458.

PMID: 35679290 PMC: 9182302. DOI: 10.1371/journal.pone.0269458.


SARS-CoV-2 Antigen Testing Intervals: Twice or Thrice a Week?.

Lau C, Aw T Diagnostics (Basel). 2022; 12(5).

PMID: 35626195 PMC: 9139623. DOI: 10.3390/diagnostics12051039.


References
1.
La Marca A, Capuzzo M, Paglia T, Roli L, Trenti T, Nelson S . Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reprod Biomed Online. 2020; 41(3):483-499. PMC: 7293848. DOI: 10.1016/j.rbmo.2020.06.001. View

2.
Zhen W, Manji R, Smith E, Berry G . Comparison of Four Molecular Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens. J Clin Microbiol. 2020; 58(8). PMC: 7383517. DOI: 10.1128/JCM.00743-20. View

3.
Corman V, Rabenau H, Adams O, Oberle D, Funk M, Keller-Stanislawski B . SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission. Transfusion. 2020; 60(6):1119-1122. PMC: 7267331. DOI: 10.1111/trf.15841. View

4.
Smith D, Duval A, Pouwels K, Guillemot D, Fernandes J, Huynh B . Optimizing COVID-19 surveillance in long-term care facilities: a modelling study. BMC Med. 2020; 18(1):386. PMC: 7721547. DOI: 10.1186/s12916-020-01866-6. View

5.
Kirkcaldy R, King B, Brooks J . COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. JAMA. 2020; 323(22):2245-2246. PMC: 8596300. DOI: 10.1001/jama.2020.7869. View